vs

Side-by-side financial comparison of Brookfield Infrastructure Corp (BIPC) and SelectQuote, Inc. (SLQT). Click either name above to swap in a different company.

Brookfield Infrastructure Corp is the larger business by last-quarter revenue ($866.0M vs $537.1M, roughly 1.6× SelectQuote, Inc.). SelectQuote, Inc. runs the higher net margin — 12.9% vs -35.7%, a 48.6% gap on every dollar of revenue. On growth, SelectQuote, Inc. posted the faster year-over-year revenue change (11.6% vs -4.6%).

Brookfield Infrastructure Partners L.P. is a publicly traded limited partnership with corporate headquarters in Toronto, Canada, that engages in the acquisition and management of infrastructure assets on a global basis.

SelectQuote is a direct-to-consumer distribution platform for selling insurance policies and healthcare services. Their insurance business earns commissions by connecting consumers with insurance carriers that provide senior health, life, automobile, and home insurance. The healthcare services business mainly consists of SelectRx, an accredited pharmacy. The company went public on May 21, 2020.

BIPC vs SLQT — Head-to-Head

Bigger by revenue
BIPC
BIPC
1.6× larger
BIPC
$866.0M
$537.1M
SLQT
Growing faster (revenue YoY)
SLQT
SLQT
+16.3% gap
SLQT
11.6%
-4.6%
BIPC
Higher net margin
SLQT
SLQT
48.6% more per $
SLQT
12.9%
-35.7%
BIPC

Income Statement — Q2 FY2025 vs Q2 FY2026

Metric
BIPC
BIPC
SLQT
SLQT
Revenue
$866.0M
$537.1M
Net Profit
$-309.0M
$69.3M
Gross Margin
65.0%
61.8%
Operating Margin
62.7%
14.0%
Net Margin
-35.7%
12.9%
Revenue YoY
-4.6%
11.6%
Net Profit YoY
-148.1%
30.2%
EPS (diluted)
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIPC
BIPC
SLQT
SLQT
Q4 25
$537.1M
Q3 25
$328.8M
Q2 25
$866.0M
$345.1M
Q1 25
$408.2M
Q4 24
$481.1M
Q3 24
$292.3M
Q2 24
$908.0M
$307.2M
Q1 24
$376.4M
Net Profit
BIPC
BIPC
SLQT
SLQT
Q4 25
$69.3M
Q3 25
$-30.5M
Q2 25
$-309.0M
$12.9M
Q1 25
$26.0M
Q4 24
$53.2M
Q3 24
$-44.5M
Q2 24
$643.0M
$-31.0M
Q1 24
$8.6M
Gross Margin
BIPC
BIPC
SLQT
SLQT
Q4 25
61.8%
Q3 25
41.4%
Q2 25
65.0%
47.2%
Q1 25
60.2%
Q4 24
67.5%
Q3 24
55.7%
Q2 24
63.8%
60.7%
Q1 24
71.8%
Operating Margin
BIPC
BIPC
SLQT
SLQT
Q4 25
14.0%
Q3 25
-12.4%
Q2 25
62.7%
-3.6%
Q1 25
5.4%
Q4 24
14.7%
Q3 24
-4.1%
Q2 24
61.9%
-0.5%
Q1 24
8.8%
Net Margin
BIPC
BIPC
SLQT
SLQT
Q4 25
12.9%
Q3 25
-9.3%
Q2 25
-35.7%
3.7%
Q1 25
6.4%
Q4 24
11.1%
Q3 24
-15.2%
Q2 24
70.8%
-10.1%
Q1 24
2.3%
EPS (diluted)
BIPC
BIPC
SLQT
SLQT
Q4 25
$0.26
Q3 25
$-0.26
Q2 25
$-0.06
Q1 25
$0.03
Q4 24
$0.30
Q3 24
$-0.26
Q2 24
$-0.17
Q1 24
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIPC
BIPC
SLQT
SLQT
Cash + ST InvestmentsLiquidity on hand
$1.2B
$18.3M
Total DebtLower is stronger
$405.8M
Stockholders' EquityBook value
$2.2B
$359.7M
Total Assets
$23.9B
$1.4B
Debt / EquityLower = less leverage
1.13×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIPC
BIPC
SLQT
SLQT
Q4 25
$18.3M
Q3 25
$10.7M
Q2 25
$1.2B
$32.4M
Q1 25
$80.1M
Q4 24
$7.3M
Q3 24
$10.4M
Q2 24
$466.0M
$42.7M
Q1 24
$37.8M
Total Debt
BIPC
BIPC
SLQT
SLQT
Q4 25
$405.8M
Q3 25
$393.1M
Q2 25
$385.1M
Q1 25
$391.5M
Q4 24
$711.9M
Q3 24
$680.4M
Q2 24
$683.3M
Q1 24
$686.0M
Stockholders' Equity
BIPC
BIPC
SLQT
SLQT
Q4 25
$359.7M
Q3 25
$305.1M
Q2 25
$2.2B
$351.1M
Q1 25
$350.2M
Q4 24
$326.0M
Q3 24
$269.4M
Q2 24
$3.5B
$316.8M
Q1 24
$346.8M
Total Assets
BIPC
BIPC
SLQT
SLQT
Q4 25
$1.4B
Q3 25
$1.2B
Q2 25
$23.9B
$1.2B
Q1 25
$1.3B
Q4 24
$1.3B
Q3 24
$1.1B
Q2 24
$23.7B
$1.2B
Q1 24
$1.2B
Debt / Equity
BIPC
BIPC
SLQT
SLQT
Q4 25
1.13×
Q3 25
1.29×
Q2 25
1.10×
Q1 25
1.12×
Q4 24
2.18×
Q3 24
2.53×
Q2 24
2.16×
Q1 24
1.98×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIPC
BIPC
SLQT
SLQT
Operating Cash FlowLast quarter
$478.0M
$52.0K
Free Cash FlowOCF − Capex
$-1.0M
FCF MarginFCF / Revenue
-0.2%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
0.00×
TTM Free Cash FlowTrailing 4 quarters
$8.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIPC
BIPC
SLQT
SLQT
Q4 25
$52.0K
Q3 25
$-21.6M
Q2 25
$478.0M
$-37.5M
Q1 25
$71.1M
Q4 24
$-28.7M
Q3 24
$-16.6M
Q2 24
$511.0M
$20.0M
Q1 24
$44.5M
Free Cash Flow
BIPC
BIPC
SLQT
SLQT
Q4 25
$-1.0M
Q3 25
$-22.7M
Q2 25
$-38.0M
Q1 25
$70.2M
Q4 24
$-29.0M
Q3 24
$-17.1M
Q2 24
$19.7M
Q1 24
$43.4M
FCF Margin
BIPC
BIPC
SLQT
SLQT
Q4 25
-0.2%
Q3 25
-6.9%
Q2 25
-11.0%
Q1 25
17.2%
Q4 24
-6.0%
Q3 24
-5.8%
Q2 24
6.4%
Q1 24
11.5%
Capex Intensity
BIPC
BIPC
SLQT
SLQT
Q4 25
0.2%
Q3 25
0.3%
Q2 25
0.1%
Q1 25
0.2%
Q4 24
0.1%
Q3 24
0.2%
Q2 24
0.1%
Q1 24
0.3%
Cash Conversion
BIPC
BIPC
SLQT
SLQT
Q4 25
0.00×
Q3 25
Q2 25
-2.91×
Q1 25
2.73×
Q4 24
-0.54×
Q3 24
Q2 24
0.79×
Q1 24
5.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BIPC
BIPC

Segment breakdown not available.

SLQT
SLQT

Healthcare Services Segment$230.7M43%
Pharmacy$227.2M42%
Other$30.4M6%
Final Expense$20.4M4%
Term$18.5M3%
Other Senior$6.3M1%
All Other Revenue$3.9M1%

Related Comparisons